Cargando…

Promoting Access to Innovative Anticancer Medicines: A Review of Drug Price and National Reimbursement Negotiation in China

Providing universal access to high-cost medications like anticancer drugs is not an easy feat. Although basic medical insurance has covered over 95% of China’s population since 2012, reimbursement for high-priced medicines is limited. In 2015, the Chinese government proposed establishing an open and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mingge, Xia, Jingyu, Wen, Qi, Liu, Zhe, Zheng, Qing, Ran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review Article (excluding Systematic Reviews)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184198/ https://www.ncbi.nlm.nih.gov/pubmed/37171066 http://dx.doi.org/10.1177/00469580231170729

Ejemplares similares

Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
por: Zhang, Yichen, et al.
Publicado: (2022)

The impacts of government reimbursement negotiation on targeted anticancer medication price, volume and spending in China
por: Zhang, Yichen, et al.
Publicado: (2021)

Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation
por: Wu, Di, et al.
Publicado: (2022)

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
por: Macabeo, Bérengère, et al.
Publicado: (2023)

Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China: An Interrupted Time Series Study
por: Zhu, Hong, et al.
Publicado: (2022)

Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?
por: Huang, Cong, et al.
Publicado: (2022)

Impact of the national drug price negotiation policy on the utilization, cost, and accessibility of anticancer medicines in China: A controlled interrupted time series study
por: Cai, Lele, et al.
Publicado: (2022)

The impact of government reimbursement negotiation on targeted anticancer medicines use and cost in China: A cohort study based on national health insurance data
por: Yang, Yu, et al.
Publicado: (2023)

The Challenge of Dental Education After COVID-19 Pandemic – Present and Future Innovation Study Design
por: Clemente, Miguel Pais, et al.
Publicado: (2021)

Pricing and reimbursement of orphan drugs: the need for more transparency
por: Simoens, Steven
Publicado: (2011)

Role of Economic Evaluations on Pricing of Medicines Reimbursed by the Italian National Health Service
por: Russo, Pierluigi, et al.
Publicado: (2022)

Using strategic price negotiations to contain costs and expand access to medicines in China
por: Si, Lei, et al.
Publicado: (2020)

A Theoretical Discussion of How Common Understanding and Reflection Upon Need for Resources Can Prevent Risks Underlying Social Innovations
por: Gjertsen, Hege
Publicado: (2023)

Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options
por: Koleva-Kolarova, Rositsa, et al.
Publicado: (2022)

Reimbursement pricing for new medical devices in Japan: Is the evaluation of innovation appropriate?
por: Tamura, Makoto, et al.
Publicado: (2018)

The correlation between the costs and clinical benefits of national price-negotiated anticancer drugs for specific cancers in China
por: Bao, Yuwen, et al.
Publicado: (2023)

Reporting quality of economic evaluations of the negotiated Traditional Chinese Medicines in national reimbursement drug list of China: A systematic review
por: Yan, Juntao, et al.
Publicado: (2023)

Approval, reimbursement and pricing of high-cost cancer medicines in Australia
por: Vitry, Agnes
Publicado: (2015)

Emergency Physician Reimbursement: Getting Shortchanged or Shrewdly Negotiating?
por: Venkatesh, Arjun K., et al.
Publicado: (2020)

Value-Based Pricing and Reimbursement in Personalised Healthcare: Introduction to the Basic Health Economics
por: Garrison, Louis P., et al.
Publicado: (2017)

Pharmaceutical pricing and reimbursement policies in Algeria, Morocco, and Tunisia: comparative analysis
por: Dahmani, Hajer, et al.
Publicado: (2023)

Physician pricing and health insurance reimbursement
por: Yett, Donald E., et al.
Publicado: (1983)

Use of medicine pricing and reimbursement policies for universal health coverage in Indonesia
por: Wasir, Riswandy, et al.
Publicado: (2019)

Understanding the trends in international agreements on pricing and reimbursement for newly marketed medicines and their implications for access to medicines: a computational text analysis
por: Son, Kyung-Bok
Publicado: (2020)

Sponsorship bias in published pharmacoeconomic evaluations of national reimbursement negotiation drugs in China: a systematic review
por: He, Zixuan, et al.
Publicado: (2023)

Negotiating prices of drugs for rare diseases
por: Henrard, Séverine, et al.
Publicado: (2016)

Payer-Negotiated Prices for Telemedicine Services
por: Wu, Shannon S., et al.
Publicado: (2022)

Pricing and reimbursement of novel oncology drugs in Sweden
por: Haglund, Mattias, et al.
Publicado: (2014)

Pharmaceutical pricing and reimbursement policies: perspectives for the future
por: Gray, Andrew L
Publicado: (2015)

Challenges and opportunities for pharmaceutical pricing and reimbursement policies
por: Vogler, Sabine, et al.
Publicado: (2015)

Financing Strategies to Facilitate Access to High-Cost Anticancer Drugs: A Systematic Review of the Literature
por: Patikorn, Chanthawat, et al.
Publicado: (2021)

Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration
por: Kamphuis, Bregtje W., et al.
Publicado: (2021)

A Heuristic Governance Framework for the Implementation of Child Primary Health Care Interventions in Different Contexts in the European Union
por: Schröder-Bäck, Peter, et al.
Publicado: (2019)

Implementation Outcomes and Indicators as a New Challenge in Health Services Research: A Systematic Scoping Review
por: Willmeroth, Tabea, et al.
Publicado: (2019)

A Meta-summarization of Qualitative Findings About Health Systems Performance Evaluation Models: Conceptual Problems and Comparability Limitations
por: Carnut, Leonardo, et al.
Publicado: (2020)

Implementation of Physical Activity Interventions in Rural, Remote, and Northern Communities: A Scoping Review
por: Pelletier, Chelsea A, et al.
Publicado: (2020)

Elderspeak to Resident Dementia Patients Increases Resistiveness to Care in Health Care Profession
por: Zhang, Min, et al.
Publicado: (2020)

Waiting Time as an Indicator for Health Services Under Strain: A Narrative Review
por: McIntyre, Daniel, et al.
Publicado: (2020)

Vision 2030 and Sustainable Development: State Capacity to Revitalize the Healthcare System in Saudi Arabia
por: Rahman, Redwanur, et al.
Publicado: (2021)

Family Members of Adults with Intellectual Disability Living in Residential Settings: Roles and Collaboration with Professionals. A Review of the Literature
por: Zambrino, Natalie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5ag0mfivn62l56d4mcjvhupkfg